STAT

STAT+: AbbVie exits major pharmaceutical industry lobbying groups

WASHINGTON — The maker of one of the world’s most profitable medicines is exiting the pharmaceutical industry’s two major lobbying organizations next year, just as Washington pledges to crack down on high drug costs.

AbbVie, which for years has fought off competition for its blockbuster autoimmune drug Humira — the world’s top-selling medicine before Pfizer’s Covid-19 vaccine hit the market — has been the target of congressional hearings and legislation aimed at so-called patent thickets that can stall rival products.

Continue to STAT+ to read the full story…

2 years 5 months ago

Politics, Advocacy, Congress, drug pricing, Medicare, Pharmaceuticals, STAT+, White House

Dominica News Online

World Aids Day 2022 address by Minister for Health, Dr. Irving McIntyre

On December 1 every year, the world commemorates World AIDS Day, the first global health day to be recognized. With this observation, we are reminded that the persons infected and affected by HIV AIDS are faced with life-altering health challenges however, they deserve...

2 years 6 months ago

Elections, Governance, News, Politics

Pages